<SEC-DOCUMENT>0001213900-26-003668-index.html : 20260113 <SEC-HEADER>0001213900-26-003668.hdr.sgml : 20260113 <ACCEPTANCE-DATETIME>20260113071031 ACCESSION NUMBER: 0001213900-26-003668 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20260113 FILED AS OF DATE: 20260113 DATE AS OF CHANGE: 20260113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SciSparc Ltd. CENTRAL INDEX KEY: 0001611746 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38041 FILM NUMBER: 26528396 BUSINESS ADDRESS: STREET 1: 20 RAUL WALLENBERG STREET, TOWER A CITY: TEL AVIV STATE: L3 ZIP: 6971916 BUSINESS PHONE: 972-3-6103100 MAIL ADDRESS: STREET 1: 20 RAUL WALLENBERG STREET, TOWER A CITY: TEL AVIV STATE: L3 ZIP: 6971916 FORMER COMPANY: FORMER CONFORMED NAME: SciSparc Ltd./ADR DATE OF NAME CHANGE: 20210129 FORMER COMPANY: FORMER CONFORMED NAME: Therapix Biosciences Ltd. DATE OF NAME CHANGE: 20140624 </SEC-HEADER> <DOCUMENT> <TYPE>6-K <SEQUENCE>1 <FILENAME>ea0272536-6k_scisparc.htm <DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER <TEXT> Document 1 - file: ea0272536-6k_scisparc.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.1 <SEQUENCE>2 <FILENAME>ea027253602ex10-1_scisparc.htm <DESCRIPTION>ASSET PURCHASE AGREEMENT, DATED JANUARY 8, 2026, BY AND BETWEEN XYLO TECHNOLOGIES LTD. AND SCISPARC LTD <TEXT> Document 2 - file: ea027253602ex10-1_scisparc.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>3 <FILENAME>ea027253602ex99-1_scisparc.htm <DESCRIPTION>PRESS RELEASE ISSUED BY SCISPARC LTD. TITLED "SCISPARC SIGNS DEFINITIVE AGREEMENT TO ACQUIRE A TREASURY OF PATENTS FOR THE ENDOSCOPE MARKET- ENTERING MULTI-BILLION DOLLAR OPPORTUNITY." <TEXT> Document 3 - file: ea027253602ex99-1_scisparc.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>ex99-1_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: ex99-1_001.jpg
</DOCUMENT> </SEC-DOCUMENT>